Få mere at vide
Irinotecan hydrochloride, Thermo Scientific™
Topoisomerase I inhibitor
1365.69 DKK - 4216.48 DKK
Kemiske identifikatorer
| CAS | 100286-90-6 |
|---|---|
| Molekylær formel | C33H39ClN4O6 |
| Molekylvægt (g/mol) | 623.15 |
| MDL nummer | MFCD01862255 |
| InChI nøgle | GURKHSYORGJETM-WAQYZQTGSA-N |
| Synonym | irinotecan hydrochloride, irinotecan hcl, topotecin, campto, cpt-11, cpt 11, camptothecin 11 hydrochloride, camptothecin 11, unii-06x131e4oe |
| PubChem CID | 74990 |
| ChEBI | CHEBI:5971 |
| IUPAC navn | hydrogen (19S)-10,19-diethyl-19-hydroxy-14,18-dioxo-17-oxa-3,13-diazapentacyclo[11.8.0.0²,¹¹.0⁴,⁹.0¹⁵,²⁰]henicosa-1(21),2(11),3,5,7,9,15(20)-heptaen-7-yl [1,4'-bipiperidine]-1'-carboxylate chloride |
| SMIL | [H+].[Cl-].CCC1=C2C=C(OC(=O)N3CCC(CC3)N3CCCCC3)C=CC2=NC2=C1CN1C2=CC2=C(COC(=O)[C@]2(O)CC)C1=O |
| Produktkode | Brand | Mængde | Pris | Antal & tilgængelighed | |||||
|---|---|---|---|---|---|---|---|---|---|
| Produktkode | Brand | Mængde | Pris | Antal & tilgængelighed | |||||
|
15473449
|
Thermo Scientific Alfa Aesar
J60743.MF |
50mg |
1365.69 DKK
50mg |
Forventet forsendelse: 09-09-2026
Log ind for at se lagerbeholdningen. |
|||||
|
Du skal Log ind eller registrere dig for at købe denne vare. Begrænset vare |
|||||||||
|
15463449
|
Thermo Scientific Alfa Aesar
J60743.MD |
250mg |
4216.48 DKK
250mg |
Forventet forsendelse: 24-08-2026
Log ind for at se lagerbeholdningen. |
|||||
|
Du skal Log ind eller registrere dig for at købe denne vare. Begrænset vare |
|||||||||
Beskrivelse
This Thermo Scientific brand product was originally part of the Alfa Aesar product portfolio. Some documentation and label information may refer to the legacy brand. The original Alfa Aesar product / item code or SKU reference has not changed as a part of the brand transition to Thermo Scientific.
Kemiske identifikatorer
| 100286-90-6 | |
| 623.15 | |
| GURKHSYORGJETM-WAQYZQTGSA-N | |
| 74990 | |
| hydrogen (19S)-10,19-diethyl-19-hydroxy-14,18-dioxo-17-oxa-3,13-diazapentacyclo[11.8.0.0²,¹¹.0⁴,⁹.0¹⁵,²⁰]henicosa-1(21),2(11),3,5,7,9,15(20)-heptaen-7-yl [1,4'-bipiperidine]-1'-carboxylate chloride |
| C33H39ClN4O6 | |
| MFCD01862255 | |
| irinotecan hydrochloride, irinotecan hcl, topotecin, campto, cpt-11, cpt 11, camptothecin 11 hydrochloride, camptothecin 11, unii-06x131e4oe | |
| CHEBI:5971 | |
| [H+].[Cl-].CCC1=C2C=C(OC(=O)N3CCC(CC3)N3CCCCC3)C=CC2=NC2=C1CN1C2=CC2=C(COC(=O)[C@]2(O)CC)C1=O |
Tekniske data
| Irinotecan hydrochloride | |
| C33H39ClN4O6 | |
| 14,5091 | |
| Soluble in DMSO or DMF at approximately 20mg/ml; Sparingly soluble in aqueous buffers; /n | |
| [H+].[Cl-].CCC1=C2C=C(OC(=O)N3CCC(CC3)N3CCCCC3)C=CC2=NC2=C1CN1C2=CC2=C(COC(=O)[C@]2(O)CC)C1=O | |
| 623.15 | |
| CHEBI:5971 |
| 100286-90-6 | |
| MFCD01862255 | |
| irinotecan hydrochloride, irinotecan hcl, topotecin, campto, cpt-11, cpt 11, camptothecin 11 hydrochloride, camptothecin 11, unii-06x131e4oe | |
| GURKHSYORGJETM-WAQYZQTGSA-N | |
| hydrogen (19S)-10,19-diethyl-19-hydroxy-14,18-dioxo-17-oxa-3,13-diazapentacyclo[11.8.0.0²,¹¹.0⁴,⁹.0¹⁵,²⁰]henicosa-1(21),2(11),3,5,7,9,15(20)-heptaen-7-yl [1,4'-bipiperidine]-1'-carboxylate chloride | |
| 74990 | |
| 623.14 |
Sikkerhed og håndtering
GHS H Statement
H302
Harmful if swallowed.
P264b-P270-P301+P312-P330-P501c
H302
missing translation for 'rtecsNumber' : DW1061000
missing translation for 'tsca' : No
Anbefalet opbevaring : Store at -20°C
- Irinotecan hydrochloride
Signalord
- Advarsel
Farekategori
- Akut toksicitet Kategori 4
Faresætning
- H302-Farlig ved indtagelse.
Sikkerhedssætning
- P264-Vask grundigt efter brug.
- P301+P330+P331-I TILFÆLDE AF INDTAGELSE: Skyl munden. Fremkald IKKE opkastning.
- P312-I tilfælde af ubehag, ring til en GIFTINFORMATION/læge/ .
Supplerende oplysninger
- MIXTURE LIST-Contain: Irinotecan hydrochloride
RUO – Research Use Only
By clicking Submit, you acknowledge that you may be contacted by Fisher Scientific in regards to the feedback you have provided in this form. We will not share your information for any other purposes. All contact information provided shall also be maintained in accordance with our Privacy Policy.